PepGen Advisory Board Participation

JavaScript isn't enabled in your browser, so this file can't be opened. Enable and reload.

Help shape the future of DM1 Drug Development at PepGen!

PepGen is looking for up to 6 to 8 adults living with myotonic dystrophy type 1 (DM1) and caregivers of adults living with myotonic dystrophy type 1 to participate in a virtual advisory board focused on building a detailed understanding of the DM patient experience.

This advisory board will help to inform PepGen's best practices for engagement and advocacy collaborations with the DM community and provide insights that reflect patient preferences and unmet needs. This virtual advisory board meeting will take place in July or August of 2022 and will take approximately 4-5 hours including preparation and pre-reading.

Learn more about PepGen at https://pepgen.com/

Please fill out the questions below to tell us more about your interest in participating in the Advisory Board. By completing this form, you authorize MDF to share your information with PepGen. Due to high levels of interest in participation, not all interested individuals will be invited to participate.

First Name *

Last Name *

Phone Number *

Geographic Location (City, state, country)

What is your relationship to myotonic dystrophy type 1? *

I am an adult living with DM1

I am a caregiver of an adult living with DM1

I am not living with nor a caregiver of an adult living with DM1.

Are you willing to participate in the 3-4 hour virtual advisory meeting this July / August?

Yes

Clear selection

Submit

Clear form

Never submit passwords through Google Forms.

This content is neither created nor endorsed by Google. - Terms of Service - Privacy Policy

Does this form look suspicious? Report

Forms